Filing Details
- Accession Number:
- 0001179110-13-000760
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2013-01-10 16:15:27
- Reporting Period:
- 2013-01-08
- Filing Date:
- 2013-01-10
- Accepted Time:
- 2013-01-10 16:15:27
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1113481 | Medicines Co | MDCO | Pharmaceutical Preparations (2834) | 043324394 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1318459 | Michael Paul Antinori | 8 Sylvan Way Parsippany NJ 07054 | Sr. Vp & General Counsel | No | Yes | No | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Common Stock | Disposition | 2013-01-08 | 3,500 | $27.90 | 49,819 | No | 4 | S | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | S | Direct |
Footnotes
- The common stock sales reported on this Form 4 were effected pursuant to a Rule 10b5-1 program adopted by Mr. Antinori on February 24, 2011.
- The range of prices for the transactions reported on this line is between $27.61 and $28.96 per share. The price reported above reflects the weighted average sales price. The undersigned undertakes, upon request by the Commission staff, the issuer or a security holder of the issuer, to provide full information regarding the number of shares sold at each separate price.